Overview
People may vary widely across many dimensions despite having the same diagnosis, which can make effective treatment a challenge. Stratified medicine aims to identify groups of people within a diverse disease population who share unique characteristics (such as underlying mechanisms, risk factors, disease trajectories, or treatment responses) to inform treatment approaches that are tailored for these groups (or strata). This webinar focuses on the value of stratification as a tool for driving transformative change in early interventions for people with anxiety, depression, and psychosis.
Speaker
Lynsey Bilsland, Ph.D.
Head of Mental Health Translation
Wellcome Trust
Dr. Lynsey Bilsland is Head of the Mental Health Translation team at Wellcome Trust, which aims to develop a portfolio of funded projects that enable identification, prediction, and early intervention in mental health problems. Dr. Bilsland also developed and led the Innovations Psychosis Flagship, which aimed to reduce the global burden of psychosis by developing innovations to improve patient outcomes.
Speaker
Arthur Caye, Ph.D.
Psychiatrist and Postdoctoral Researcher
Universidad Federal do Rio Grande do Sul, Brazil
Dr. Arthur Caye is a child and adolescent psychiatrist and a post-doctoral researcher at Universidade Federal do Rio Grande do Sul, Brazil. He has worked with predictive models for the last six years, developing and replicating risk scores to predict the onset of adolescent depression (the IDEA-RS) and the persistence/onset of attention-deficit/hyperactivity in adulthood. He has also collaborated with UNICEF’s State of the World’s Children Report specifically to discuss risk factors for child and adolescent mental disorders worldwide. Arthur joined the Identifying Depression Early in Adolescence research consortium to help conceptualize and develop the IDEA-RS. Currently, he is the research manager of the National Center for Research and Innovation in Mental Health, which received the largest funding ever dedicated to psychiatry and mental health in Brazil.
Speaker
Usman Hamdani, Ph.D.
Research Lead, Mental Health Translation
Wellcome Trust
Dr. Usman Hamdani is the Research Lead in the Mental Health Translation team at Wellcome Trust, where he leads the portfolio of non-pharmacological interventions and stratification in mental health research. Before joining Wellcome, Dr. Hamdani was extensively involved in conducting cutting-edge trials of psychosocial interventions in global mental health research and policy impact in low-resource settings.
Speaker
Wesley Horton
Senior Scientific Project Manager
Foundation for the National Institutes of Health
Wesley Horton is a translational neuroscientist with a Master of Science degree in Clinical and Translational Research from Georgetown University and a Bachelor of Science degree in Psychology from the University of Mary Washington. He has launched and managed multiple public-private partnerships in neuroscience, focusing on drug development for mental health and neurodegeneration. He has also managed Alzheimer’s disease clinical trials and developed clinical research portfolios across various fields such as stroke, neurosurgery, and interventional radiology. Additionally, Wesley has experience managing international multi-center clinical trials focused on understanding HIV and HIV-associated neurocognitive disorders, in collaboration with the Department of Defense and Henry M. Jackson Foundation.